Zimmer Holdings, Inc.  

(Public, NYSE:ZMH)   Watch this stock  
Find more results for Zimmer Holdings, Inc
102.14
+1.21 (1.20%)
Real-time:   3:18PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 101.28 - 102.46
52 week 78.00 - 108.33
Open 101.30
Vol / Avg. 1.16M/1.07M
Mkt cap 17.13B
P/E 22.31
Div/yield 0.22/0.86
EPS 4.58
Shares 167.70M
Beta 0.99
Inst. own 85%
Oct 22, 2014
Q3 2014 Zimmer Holdings Inc Earnings Release (Estimated) - 7:00AM EDT - Add to calendar
Jul 24, 2014
Q2 2014 Zimmer Holdings Inc Earnings Call
Jul 24, 2014
Q2 2014 Zimmer Holdings, Inc. Earnings Release
May 6, 2014
Zimmer Holdings, Inc. Annual Shareholder Meeting
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 14.89% 16.42%
Operating margin 21.92% 22.40%
EBITD margin - 34.84%
Return on average assets 7.43% 8.17%
Return on average equity 11.16% 12.52%
Employees 9,500 -
CDP Score - 62 E

Address

345 East Main Street
WARSAW, IN 46580
United States - Map
+1-574-2676131 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Zimmer Holdings, Inc. (Zimmer) designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. The Company�s customers include orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. It manages its operations through three geographic segments: the Americas, which is consisted of the United States and includes other North, Central and South American markets; Europe, which is consisted of Europe and includes the Middle East and Africa markets, and Asia Pacific, which is consisted of Japan and Australia and includes other Asian and Pacific markets. In May 2013, Zimmer Holdings Inc acquired Knee Creations LLC. In June 2013, Zimmer Holdings Inc acquired NORMED Medizin Technik GmbH.

Officers and directors

David C. Dvorak President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
James T. Crines Chief Financial Officer, Executive Vice President - Finance
Age: 54
Bio & Compensation  - Reuters
Joseph A. Cucolo President, Americas Sales
Age: 54
Bio & Compensation  - Reuters
Katarzyna Mazur-Hofsaess M.D., Ph.D. President, Europe, Middle East and Africa
Age: 50
Bio & Compensation  - Reuters
Stephen H. L. Ooi President, Asia Pacific
Age: 60
Bio & Compensation  - Reuters
Chad F. Phipps Senior Vice President, General Counsel, Secretary
Age: 42
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Derek M. Davis Vice President - Finance, Chief Accounting Officer, Corporate Controller
Age: 45
Bio & Compensation  - Reuters
John L. McGoldrick Independent Non-Executive Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
Christopher B. Begley Independent Director
Age: 61
Bio & Compensation  - Reuters
Betsy J. Bernard Independent Director
Age: 59
Bio & Compensation  - Reuters